Department of Medicine

Speakers at the inaugural SCRIPS Spring Symposium (Supporting Careers in Research for Interventional Physicians and Surgeons) last week were, from left, Kelle Moley, MD, senior vice president and chief scientific officer of the March of Dimes; 2018 SCRIPS Scholars Yash Choksi, MD, and Akshitkumar Mistry, MD; and Anil Rustgi, MD, the T. Grier Miller Professor of Medicine and Genetics at the University of Pennsylvania’s Perelman School of Medicine and incoming director of the Herbert Irving Comprehensive Cancer Center in New York. The SCRIPS program is supported by the Burroughs Wellcome Fund.
March 28, 2019

SCRIPS Symposium

Speakers at the inaugural SCRIPS Spring Symposium (Supporting Careers in Research for Interventional Physicians and Surgeons) last week were, from left, Kelle Moley, MD, senior vice president and chief scientific officer of the March of Dimes; 2018 SCRIPS Scholars Yash Choksi, MD, and Akshitkumar Mistry, MD; and Anil Rustgi, MD.

March 28, 2019

Cancer prevention drug also disables H. pylori bacterium

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.

Longtime colleagues and friends Curt Thorne, left, and Terry Burke enjoyed sailing together.
March 28, 2019

Bladder cancer research fund honors mentor’s lasting influence

The Terry Burke Fund for Bladder Cancer Research at Vanderbilt-Ingram Cancer Center is supporting a range of discovery research aimed at improving outcomes for bladder cancer patients, and it is helping train the next generation of bladder cancer physician-scientists.

March 14, 2019

Reprogramming cells for kidney repair

Using gene transfer technologies to reprogram adult human kidney cells could lead to novel therapies for chronic kidney disease.

March 14, 2019

Cancer Center Ambassadors surpass $1 million in grants

Vanderbilt-Ingram Cancer Center Ambassadors surpassed the $1 million mark with the awarding of the group’s latest research grants.

February 28, 2019

Achilles’ heel for kidney cancer

The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.